To further extend previous studies, which focused on the expression pattern of AXL in cancer and especially in glioma tissue [13], we studied the expression pattern of the biologically active AXL receptor (P-AXL) in GBM tissue in order to identify subgroups of patients suitable for future anti-AXL therapy. This evidence concerns the gene AXL and central nervous system cancer.